Audit 370393

FY End
2024-12-31
Total Expended
$1.39M
Findings
4
Programs
2
Year: 2024 Accepted: 2025-10-03

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
1159854 2024-001 Material Weakness Yes C
1159855 2024-002 Material Weakness Yes M
1159856 2024-001 Material Weakness Yes C
1159857 2024-002 Material Weakness Yes M

Programs

Contacts

Name Title Type
LJYNSENQXKM5 Tricia Hoffine Auditee
7045622004 John Di Santo Auditor
No contacts on file

Notes to SEFA

The accompanying Schedule of Expenditures of Federal Awards (the Schedule) presents the activity of each federal program for the year ended December 31, 2024 of IMEC USA Nanoelectronics Design Center, Inc. (IMEC USA). The information in this Schedule is presented in accordance with Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance).
The purpose of the Schedule is to present, in summary form, total expenditures of federal awards received by IMEC USA for the year ended December 31, 2024. The Schedule is prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America. The information in this Schedule is presented in accordance with the requirements of the Uniform Guidance. Because the Schedule presents only a selected portion of the results of operations of IMEC USA, it is not intended to and does not present either the financial position or results of operations of IMEC USA.
Grant revenue amounts received are subject to audit and adjustment. If any expenditure is disallowed by the grantor agencies as a result of such an audit, any claim for reimbursement to the grantor agencies would become a liability to IMEC USA. In the opinion of management, all grant expenditures are in compliance with the terms of the grant agreement and applicable federal laws and regulations.
IMEC USA has elected to use the 10% de minimis indirect cost rate allowed by the Uniform Guidance for NSF Technology, Innovation and Partnerships, and a negotiated rate of 20% indirect cost rate for Basic Scientific Research

Finding Details

Finding No. 2024-001 – Cash Management | Identification of the Program: | Program Name: Research and Development Cluster: Basic Scientific Research, Department of Defense Awarding Office, 12.431; NSF Technology, Innovation and Partnerships, National Science Foundation, 47.084 | Criteria or Specific Requirements (Including Statutory, Regulatory, or Other Citations): 2 CFR 200.303 requires that a non-Federal entity must “(a) establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States and the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).” According to page 3-C-5 of the 2024 OMB Compliance Supplement, expenses must be incurred before submitting a reimbursement request (2 CFR § 200.305(b)(3)). | Condition: During our testing of 2024 reimbursement requests (totaling $536,272), we noted that there was no evidence of review and approval of the requests to indicate whether the reviewer determined that expenditures submitted for reimbursement had been incurred prior to the request for reimbursement. Management has indicated this review does, in fact, take place, however, there is no evidence (i.e., sign off) on the request to indicate that the review had occurred. | Section III— Federal Award Findings and Questioned Costs (continued) | Cause: Internal controls over the review and approval of the reimbursement requests were not effective. | Effect or Potential Effect: This could result in reimbursement for expenditures that have not been incurred and paid prior to reimbursement being requested. | Questioned Costs: None. | Context: As the sample size is small, we selected 10 cash disbursements for testing. There was no evidence of approval for all 10 reimbursement requests. | Identification as a Repeat Finding: N/A – This is a first year Uniform Guidance audit. | Recommendation: Management should strengthen its internal controls over cash management related to reimbursement requests by having the reviewer sign off on the reimbursement request to support that the review had occurred. | View of Responsible Officials: Management concurs with the findings and has developed a corrective action plan to address this finding.
Finding No. 2024-002 – Subrecipient Monitoring | Identification of the Program: | Program Name: Research and Development Cluster: Basic Scientific Research, Department of Defense Awarding Office, 12.431; NSF Technology, Innovation and Partnerships, National Science Foundation, 47.084 | Criteria or Specific Requirements (Including Statutory, Regulatory, or Other Citations): 2 CFR 200.303 requires that a non-Federal entity must “(a) establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States and the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).” According to page 3-M-1 of the 2024 OMB Compliance Supplement, management is responsible for monitoring activities designed to evaluate subrecipient risk as required by the terms and conditions of the award. Such activities include: reviewing financial reports; following up and ensuring that the subrecipient takes timely and appropriate action on all deficiencies detected through audits, on-site reviews, and other; issuing a management decision for audit findings pertaining to the federal award provided to the subrecipient from the PTE as required by 2 CFR section 200.521. | Section III— Federal Award Findings and Questioned Costs (continued) | Condition: During our testing of 2024 subrecipient monitoring activities, we selected five subrecipients for testing noting that there was no evidence of management’s evaluation of each subrecipient or management’s review of the specific monitoring procedures performed. Through inquiry, management acknowledged that they complete an evaluation form for each subrecipient prior to contracting with the subrecipient although an evaluation of the risk of the subrecipient is not included on the form. Management also informed us that they review all expenditures and related supporting documentation provided by the subrecipient prior to paying their invoices, although evidence of performing such a review is not documented. | Cause: Internal controls over the review and approval of the subrecipient monitoring were not effective. | Effect or Potential Effect: This could result in granting subawards to and paying subrecipients who are of higher risk for compliance and/or subrecipients who have not been properly monitored to ensure they are complying with the grant terms. | Questioned Costs: None. | Context: As the sample size is small, we selected 5 subrecipients for testing out of a total of 5 subrecipients. | Identification as a Repeat Finding: N/A – This is a first year Uniform Guidance audit.